People will vary in how they respond
Previous studies have shown a potential link between GLP-1 use and Now, a new study published in the British Journal of Ophthalmology reports that Wegovy users may be at the highest risk of developing ischemic optic neuropathy (ION) an umbrella term for conditions including NAION when compared to other semaglutide-based GLP-1s
Gray M, Miles K, Salter D, Gray D, Savill J
Routine biochemical analyses, mixed meal tolerance tests (MMTT), and 14-day continuous glucose monitoring (CGM) were performed at the end of each diet
These studies have achieved quantifiable therapeutic effects at the mouse/rat level and may provide new targets for drug development[67]
47(4): 75860 Panzetta G, Bonadonna G, Giovene P, et al